• Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Newsroom
    • Careers
CONTACT US

SIGN IN

  • Data
  • Studio
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Governance
    • Newsroom
    • Careers
Ozempic, Wegovy, and Mounjaro: On- and off-label prescribing trends

Ozempic, Wegovy, and Mounjaro: On- and off-label prescribing trends

by Truveta Research | Jun 6, 2023 | Research, Research Insights

Beginning in Fall 2022, the news media has reported extensively on the use of Glucagon-like peptide-1 receptor agonist (GLP-1s) for weight loss (Belluz, 2023). Physicians have taken to TikTok to promote GLP-1s for weight loss, and celebrities & influencers – such...
Q&A: Exploring with The Wall Street Journal Truveta’s EHR data on speech delays

Q&A: Exploring with The Wall Street Journal Truveta’s EHR data on speech delays

by Truveta Staff | May 19, 2023 | Culture, News, Research, Research Insights

The Wall Street Journal recently published a story, If Your Toddler Isn’t Talking Yet, the Pandemic Might Be to Blame, based on a new pre-print published by Truveta Research on MedRxiv, which investigated speech delays in children under age 5 as an unexpected outcome...
Truveta collaboration with Harvard University researchers published in JAMA Network Open

Truveta collaboration with Harvard University researchers published in JAMA Network Open

by Truveta Research | May 11, 2023 | News, Research, Research Insights

Today Truveta announced a new research letter published in JAMA Network Open using de-identified patient data from Truveta Studio. Published in collaboration with Anupam B. Jena, MD, PhD and Christopher M Worsham, MD, MPH from Harvard University, the new research...
Comparative effectiveness of SGLT2i vs. Metformin for first-line antidiabetic treatment

Comparative effectiveness of SGLT2i vs. Metformin for first-line antidiabetic treatment

by Truveta Research | May 9, 2023 | Research, Research Insights

This blog is an extension of our poster presented at ISPOR, titled Real-World Effectiveness of SGLT2 Inhibitors Vs Metformin as First-Line Therapy in Type 2 Diabetes.   Individuals with type 2 diabetes mellitus (T2DM) have a higher risk of cardiovascular disease...
The effect of the opioid crisis on babies

The effect of the opioid crisis on babies

by Truveta Research | Apr 30, 2023 | Research, Research Insights

Since the 1990s, the negative impact of prescription opioids – particularly death from overdose – have become an epidemic in the US (Centers for Disease Control and Prevention, 2022; Paulozzi et al., 2011). More recently, in the early 2010s, the US embarked on a new...
Huddle up: Injury comparisons across sports

Huddle up: Injury comparisons across sports

by Truveta Research | Apr 27, 2023 | Research, Research Insights

While many adults engage in sports, even more children participate in sports (Blendon et al., 2015). A 2020 report suggests that over 50% of children between 6-17 have participated in sports within the last year (Black et al., 2022), which is an increase from under...
« Older Entries

Recent Posts

  • Ozempic, Wegovy, and Mounjaro: On- and off-label prescribing trends
  • A pragmatic suggestion for medical AI regulation
  • Unlocking Insights: Stroke Research with Truveta
  • Truveta Spotlight: Dr. Marty Doerfler, EVP of Healthcare
  • Q&A: Exploring with The Wall Street Journal Truveta’s EHR data on speech delays

Categories

  • Culture
  • News
  • Research
  • Research Insights
  • Technology

Archive

  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • March 2021
  • February 2021
  • December 2020
  • October 2020

Ready to join us on our mission of Saving Lives with Data?

Get started
  • Follow
  • Follow

Truveta Data

Truveta Studio

Research

Resources

Blog

Leadership

Governance

Newsroom

Careers

Contact us

Privacy Notice

© Truveta 2023

Interested in learning more?

Reach out and we’ll schedule a demo.